|1.||Shimizu, Hiroyuki: 1 article (11/2010)|
|2.||Takebe, Yutaka: 1 article (11/2010)|
|3.||Arita, Minetaro: 1 article (11/2010)|
|4.||Wakita, Takaji: 1 article (11/2010)|
|5.||Rombaut, Bart: 1 article (01/2008)|
|6.||Merckx, Ellen: 1 article (01/2008)|
|7.||Vrijsen, Raf: 1 article (01/2008)|
|8.||Steurbaut, Stephane: 1 article (01/2008)|
|9.||Nikolaeva, L: 1 article (04/2000)|
|10.||Galabov, A S: 1 article (04/2000)|
12/01/1982 - "The efficacy of a nasal-spray formulation of enviroxime was tested as pretreatment or as postchallenge treatment for rhinovirus type 4 infection. "
01/01/1985 - "Controlled trial of enviroxime against natural rhinovirus infections in a community."
06/01/1982 - "The combined results of two separate trials yielded an infection rate of 100% for 21 placebo-treated and 89% for 19 enviroxime-treated subjects. "
11/01/2010 - "These results suggest that AN-12-H5 is a bifunctional anti-enterovirus compound that belongs to a novel class of enviroxime-like compounds and targets both a replication step and an early stage of EV71 infection."
05/01/1983 - "Enviroxime given 6 times a day was well tolerated, producing a reduction in clinical evidence of infection which coincided with the start of medication (44 h after virus challenge). "
11/01/1987 - "In this study we also report on the synergistic interaction between these new synthetic substances and also with some of the earlier compounds such as DCF and enviroxime and we discuss the possible implication of this synergistic activity regarding the future prevention and treatment of common colds caused by rhinoviruses."
01/01/1985 - "The therapeutic effect of intranasally administered enviroxime was tested against naturally occurring common colds. "
|3.||Acute Hemorrhagic Conjunctivitis
|1.||Interferon-alpha (Interferon Alfa)
|2.||Interferon-gamma (Interferon, gamma)
|7.||6- (((hydroxyimino)phenyl)methyl)- 1- ((1- methylethyl)sulfonyl)- 1H- benzimidazol- 2- amine